Skip to main content
SpringerLink
Log in

Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Methylenetetrahydrofolate reductase (MTHFR) polymorphism may play an important role in the pathophysiology of obesity and diabetes accompanied by obesity due to its influence on plasma homocysteine levels. There are significant and sometimes very strong relationship between levels of homocysteine and several multi-system diseases including CHD and CVA. To examine the association between MTHFR gene C677T polymorphism in diabetes and obesity with serum homocysteine levels. A total of 682 subjects were recruited in four groups (Normal, obese, diabetic and obese and diabetics). MTHFR gene C677T polymorphism was detected using PCR-RFLP technique. Serum homocysteine levels were measured using HPLC. There was a significant increase in the mean serum homocysteine levels in subjects carrying TT genotype (34.6 ± 26.5) compared to subjects carrying CC (15.1 ± 8) or CT genotype (16.4 ± 7.8) (P < 0.000). We found no significant differences for MTHFR allele and genotype frequencies between different groups. Our data have confirmed the association between serum homocysteine levels and MTHFR C677T genotype reported in other populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Refsume H, Ueland PM (1998) Recent data are not in conflict with homocystein as a cardiovascular risk factor. Curr Opin Lipidol 9:533–539. doi:10.1097/00041433-199812000-00004

    Article  Google Scholar 

  2. Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J et al (1998) Characterization of the stress-inducing effects of homocysteine. Biochem J 332:213–221

    CAS  PubMed  Google Scholar 

  3. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr et al (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012–17017. doi:10.1074/jbc.272.27.17012

    Article  CAS  PubMed  Google Scholar 

  4. Freitas AI, Mendonca I, Guerra G, Brion M, Reis RP, Carracedo A, Brehm A (2008) Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymprphism does matter. Inferences from a case study (Madeira, Portugal). Thromb Res 122:648–656. doi:10.1016/j.thromres.2008.02.005

    Article  CAS  PubMed  Google Scholar 

  5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthew RG et al (1995) A candidate genetic risk factors for vascular disease: a common mutation in methylenetetrahydrofolate reductase: isolation of Cdna, mapping and mutation identification. Nat Genet 10:110–113. doi:10.1038/ng0595-111

    Article  Google Scholar 

  6. Rassoul F, Richter V, Hentschel B, Geisel J, Herrmann W, Kuntze T (2008) Plasma homocysteine levels & 677C→T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J Med Res 127:154–158

    CAS  PubMed  Google Scholar 

  7. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002) MTHFR studies collaboration group. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–2031

    Article  CAS  PubMed  Google Scholar 

  8. Inamoto N, Katsuya T, Kokubo Y, Mannami T, Asai T, Baba S et al (2003) Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 34:1628–1633. doi:10.1161/01.STR.0000075769.09092.82

    Article  CAS  PubMed  Google Scholar 

  9. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma and serum: methods and clinical applications. Clin Biochem 93:1764–1779

    Google Scholar 

  10. Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset S et al (1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (equal to or greater than 40 micromole/liter): the Hordaland homocysteine study. J Clin Invest 98:2174–2183. doi:10.1172/JCI119024

    Article  CAS  PubMed  Google Scholar 

  11. Frosst P, Zhang Z-X, Pai A, Rozen R (1996) The methylenetetrahydrofolate reductase (Mthfr) gene maps to distal mouse chromosome 4. Mamm Genome 7:864–869. doi:10.1007/s003359900255

    Article  CAS  PubMed  Google Scholar 

  12. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9

    CAS  PubMed  Google Scholar 

  13. Thawnashom K, Tungtrongchitr R, Petmitr S, Pongpaew P, Phonrat B, Tungtrongchitr A, Schelp FP (2005) Methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) in relation to homocysteine concentration in overweight and obese Thais. Southeast Asian J Trop Med Public Health 36:459–466

    CAS  PubMed  Google Scholar 

  14. Terruzzi I, Senesi P, Fermo I, Lattuada G, Luzi L (2007) Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J Endocrinol Invest 30:747–753

    CAS  PubMed  Google Scholar 

  15. Song C, Xing D, Tan W, Wei Q, Lin D (2001) Methylenetetrahydrofolate reductase gene polymorphism increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61:3272–3275

    CAS  PubMed  Google Scholar 

  16. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230–236. doi:10.1056/NEJM199707243370403

    Article  PubMed  Google Scholar 

  17. Molloy AM, Daly S, Mills JL et al (1997) Thermolabile variant of 5, 10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349:1591–1593. doi:10.1016/S0140-6736(96)12049-3

    Article  CAS  PubMed  Google Scholar 

  18. Ma J, Stampfer MJ, Giovannucci E et al (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57:1098–1102

    CAS  PubMed  Google Scholar 

  19. Ma J, Stampfer MJ, Christensen B et al (1999) A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8:825–829

    CAS  PubMed  Google Scholar 

  20. Gallisti S, Sudi k, Mangge H, Erwa W, Borkenstein M (2000) Insuline is an independent correlate of plasma homocusteine levels in obese children and adolescents. Diabetes Care 23:1348–1352. doi:10.2337/diacare.23.9.1348

    Article  Google Scholar 

  21. Ruiz JR, Hurtig-Wennlof A, Ortega FB, Patterson E, Nilsson TK et al (2007) Homocysteine levels in children and adolescents are associated with the methylenetetrahydrofolate reductase 677C>T genotype, but not with physical activity, fitness or fatness: the European youth heart study. Br J Nutr 97:255–262. doi:10.1017/S0007114507280535

    Article  CAS  PubMed  Google Scholar 

  22. Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D (2001) Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs 1:353–361. doi:10.2165/00129784-200101050-00005

    Article  CAS  PubMed  Google Scholar 

  23. Virtanen JK, Voutilainen S, Alfthan G, Korhonen MJ, Rissanen TH, Mursu J, Kaplan GA, Salonen JT (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio ischaemic heart disease risk factor (KIHD) study. J Intern Med 257:255–262. doi:10.1111/j.1365-2796.2005.01450.x

    Article  CAS  PubMed  Google Scholar 

  24. Vrentzos GE, Papadakis JA, Malliaraki N, Zacharis EA, Mazokopakis E, Margioris A, Ganotakis ES, Kafatos A (2004) Diet, serum homocysteine levels and ischaemic heart disease in a Mediterranean population. Br J Nutr 91:1013–1019

    Article  CAS  PubMed  Google Scholar 

  25. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case–control studies and nested case–control studies. Int J Epidemiol 31:59–70. doi:10.1093/ije/31.1.59

    Article  PubMed  Google Scholar 

  26. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483. doi:10.1056/NEJMoa011613

    Article  CAS  PubMed  Google Scholar 

  27. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049. doi:10.1056/NEJMoa032739

    Article  CAS  PubMed  Google Scholar 

  28. Hague WM (2003) Homocysteine and pregnancy. Best Pract Res Clin Obstet Gynaecol 17:459–469. doi:10.1016/S1521-6934(03)00009-9

    Article  PubMed  Google Scholar 

  29. Russo GT, Di Benedetto A, Alessi E et al (2006) Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. J Endocrinol Invest 29:201–207

    CAS  PubMed  Google Scholar 

  30. Di Renzo L, Bigioni M, Del Gobbo V et al (2007) Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res 55:131–138. doi:10.1016/j.phrs.2006.11.002

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by Endocrinology and Metabolism Research center of Tehran University of Medical Sciences. We thank the head, academic and support staff and laboratory of EMRC.

Author information

Authors and Affiliations

  1. Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran

    Javad Tavakkoly Bazzaz, Parvin Amiri, Hossein Fakhrzadeh, Ramin Heshmat, Maryam Parvizi, Shirin Hasani Ranjbar & Mahsa M. Amoli

  2. Department of Science, Payamnoor University, Tehran, Iran

    Mahnaz Shojapoor & Habibollah Nazem

  3. EMRC, Dr Shariati Hospital, North Karegar St., 14114, Tehran, Iran

    Mahsa M. Amoli

Authors
  1. Javad Tavakkoly Bazzaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahnaz Shojapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Habibollah Nazem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parvin Amiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hossein Fakhrzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ramin Heshmat
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maryam Parvizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shirin Hasani Ranjbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mahsa M. Amoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahsa M. Amoli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tavakkoly Bazzaz, J., Shojapoor, M., Nazem, H. et al. Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity. Mol Biol Rep 37, 105–109 (2010). https://doi.org/10.1007/s11033-009-9545-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9545-z

Keywords

Search

Navigation